View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
ABGSC Capital Goods Research ... (+2)
  • ABGSC Capital Goods Research
  • Karl Bokvist

Serial acquirers Q1 recap: organic slowdown continues

Q1 recap: lower volumes, but strong margins, 1-3% adj. EBITA miss, '24e-'26e EBITA down 1-0% post-Q1, sector up 13% YTD (EPS up 5%), now trading at ~22x F12m EV/EBITA, 25% above 10Y avg.

ABGSC Capital Goods Research ... (+2)
  • ABGSC Capital Goods Research
  • Karl Bokvist

Organic profit momentum continues to impress

Negative org. sales, but org. EBITA stays positive, '24/'25e-'26/'27e EBITA up 2-1%; 6% CAGR '23-'26e, keep HOLD, TP SEK 255 (245)

ABGSC Capital Goods Research ... (+2)
  • ABGSC Capital Goods Research
  • Karl Bokvist
Karl Bokvist ... (+2)
  • Karl Bokvist
  • Max Bacco

Addtech - At times like these Addtech grows with ease

6% EBITA beat as organic growth excels again (19%) ‘22/’23e-‘24/25e EBITA up 4-2%; 8% CAGR ’21-‘24e Keep HOLD, TP SEK 150 (150)

Karl Bokvist ... (+2)
  • Karl Bokvist
  • Max Bacco

Addtech - 6% EBITA beat on strong 19% organic growth

Sales +5%, EBITA +6% vs. cons, 19% organic growth Consensus to raise ‘22e-‘24e EBITA by 3-1% Solid, but so have peers; slight negative reaction likely

Karl Bokvist ... (+2)
  • Karl Bokvist
  • Max Bacco

Addtech - Heads-up for report 27 October

Addtech will report calendar Q3 (fiscal Q2) on Thursday, 27 October, at 08:00 CET. A conference call will follow at 10:00, dial in: SE , UK

Karl Bokvist ... (+2)
  • Karl Bokvist
  • Max Bacco

Sector Report - Stronger for longer

Down to HOLD (Buy), TP SEK 150 (165) Calendar Q3 (fiscal Q2) report on Thursday, 27 October

Karl Bokvist ... (+2)
  • Karl Bokvist
  • Max Bacco

Addtech - Few worries, except valuation

Down to HOLD (Buy), TP SEK 150 (165) ’22/’23e EBITA +3%, ’23/’24e-’24/’25e EBITA down 3-2% Calendar Q3 (fiscal Q2) report on Thursday, 27 October

Karl Bokvist ... (+2)
  • Karl Bokvist
  • Max Bacco

Addtech - No signs of a slowdown in demand yet

Sales +9% vs. cons, adj. EBITA +13%; 17% org. growth Demand increasing sequentially, Q2 off to a good start Solid balance sheet and strong M&A pipeline

Karl Bokvist ... (+2)
  • Karl Bokvist
  • Max Bacco

Addtech - Heads-up for report 15 July

Addtech will report Q1 on Friday, 15 July. A conference call will follow at 10:00 CEST, dial in: SE 1, UK 4, pin: 22846167#

Karl Bokvist ... (+2)
  • Karl Bokvist
  • Max Bacco

Sector Report - Take away M&A and you still see quality

Q1’22/23 report due Friday, 15 July ‘22e-‘24e adj. EBITA up 2-0% on M&A and FX Up to BUY (Hold) – TP of SEK 160 (182)

Karl Bokvist ... (+2)
  • Karl Bokvist
  • Max Bacco

Addtech - High quality no longer at a premium - BUY

Q1’22/23 report due Friday, 15 July ‘22e-‘24e adj. EBITA up 2-0% on M&A and FX Up to BUY (Hold) – TP of SEK 160 (182)

Karl Bokvist ... (+2)
  • Karl Bokvist
  • Max Bacco

Addtech - High quality still at a premium

Beats expectations for fourth quarter in a row Strong demand continues, with a loaded M&A pipeline ‘22/23-’24/25 adj. EBITA estimates up 6-8%

Karl Bokvist ... (+2)
  • Karl Bokvist
  • Max Bacco

Addtech - Heads-up for report 17 May

Addtech will report its Q4 results on Tuesday 17 May. A conference call will follow at 10:00, dial in: SE: 7, UK: 8

Karl Bokvist ... (+2)
  • Karl Bokvist
  • Max Bacco

Sector Report - Divergence between ST woes and LT gains

Q4’21/22 report due Tuesday 17 May Potentially the last quarter with double-digit organic growth 21x ’23/24e EV/EBITA in M&A scenario

Karl Bokvist ... (+2)
  • Karl Bokvist
  • Max Bacco

Addtech - Showcasing its resilient business model

Q4’21/22 report due Tuesday 17 May Potentially the last quarter with double-digit organic growth 21x ’23/24e EV/EBITA in M&A scenario

Karl Bokvist ... (+2)
  • Karl Bokvist
  • Max Bacco

Addtech - High quality at a premium

Changing our coverage from sponsored to rated research M&A scenario implies 15% ’21/22e-’26/27e EBITA CAGR HOLD, TP SEK 170, 7% upside

Karl Bokvist ... (+2)
  • Karl Bokvist
  • Max Bacco

Addtech - Terminating coverage

ABGSC terminates sponsored coverage of Addtech Coverage will be transferred to institutional research Last published estimates are shown in this report

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch